2.1. Study design
dysphagia, VF, cancer, hypopharyngeal, oropharyngeal, Cancer
DYSPHAGIA, CANCER, ADVERSE EVENT, CANCER
This clinical trial, currently ongoing at Nara Medical University Hospital, is a prospective, single-center, single-arm, non-blind, non-randomized clinical trial involving patients with oropharyngeal (OPC) or hypopharyngeal (HPC) cancer who undergo CRT or RT as the standard cancer treatment. Participants will undergo rehabilitation for dysphagia (RD) and several examinations, including TP measurement, VE, VF, cervical computed tomography, ultrasound examination, blood test, chest radiography, electrocardiogram, and respiratory function test. Moreover, AEs will be evaluated according to the Common Terminology Criteria for Adverse Events Version 5.0, as proposed by the National Cancer Institute.